Tandem Diabetes Care (TNDM) Receivables - Net (2016 - 2025)
Tandem Diabetes Care (TNDM) has disclosed Receivables - Net for 13 consecutive years, with $125.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Net rose 17.49% year-over-year to $125.9 million, compared with a TTM value of $125.9 million through Sep 2025, up 17.49%, and an annual FY2024 reading of $114.6 million, up 8.55% over the prior year.
- Receivables - Net was $125.9 million for Q3 2025 at Tandem Diabetes Care, down from $134.5 million in the prior quarter.
- Across five years, Receivables - Net topped out at $134.5 million in Q2 2025 and bottomed at $73.7 million in Q1 2021.
- Average Receivables - Net over 5 years is $104.9 million, with a median of $103.8 million recorded in 2022.
- The sharpest move saw Receivables - Net surged 74.14% in 2021, then fell 11.33% in 2023.
- Year by year, Receivables - Net stood at $110.7 million in 2021, then grew by 7.51% to $119.0 million in 2022, then dropped by 11.33% to $105.6 million in 2023, then increased by 8.55% to $114.6 million in 2024, then rose by 9.91% to $125.9 million in 2025.
- Business Quant data shows Receivables - Net for TNDM at $125.9 million in Q3 2025, $134.5 million in Q2 2025, and $133.7 million in Q1 2025.